	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	175.62	166.41	195.75	5.5%	-10.3%
Operating Profit Qtr	20.18	19.84	21.69	1.7%	-7.0%
Net Profit Qtr	9.68	10.40	18.62	-6.9%	-48.0%
Earning Per Share Adjusted latest Qtr	2.00	2.15	3.86	-7.0%	-48.2%

* Consolidated data

Detailed Results

Kopran Ltd.

13 May 2025

186.89

0.98%

Company Update

Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Credit rating updates by CRISIL

pdf

Kopran Ltd.

07 May 2025

186.89

0.98%

Board Meeting

Kopran Ltd - 524280 - Board Meeting Intimation for Audited Financial Results Q4 2024-25

BSE India

Kopran Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve Standalone and Consolidated Audited Financial Result of the Company for the Quarter and Financial Year ended March 31, 2025 and Dividend, if any

pdf

Kopran Ltd.

28 Apr 2025

186.89

0.98%

Company Update

Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Closure of USFDA inspection at Kopran Research Laboratories Limited (wholly owned subsidiary), API unit located at Mahad, Maharashtra.

pdf

Kopran Ltd.

18 Apr 2025

186.89

0.98%

Company Update

Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

BSE India

Draft Scheme of Amalgamation( Merger by Absorption) of Kopran Laboratories Limited (Transferor Company) with Kopran Limited (Transferee Company) and their respective shareholders and creditors.

pdf

Is Kopran Ltd. worth buying?

179 Votes:

Buy 84.92%

Sell 10.06%

Hold 5.03%